Circular Genomics has secured exclusive rights from Washington University and Max Delbrück Center to develop a blood-based Alzheimer’s test using circular RNA biomarkers.
Read More
A large-scale international trial is evaluating a finger prick blood test for Alzheimer’s, analyzing three protein biomarkers as a potential alternative to PET scans and lumbar punctures.
Read More
A 44-metabolite blood test signature identified by Mass General Brigham and Einstein researchers improved type 2 diabetes risk prediction in a study of over 23,000 participants, according to Nature Medicine.
Read More
Study using pTau217 assay finds more than one in 10 adults over age 70 may be eligible for treatments to slow cognitive decline.
Read More
A longitudinal study finds blood-based biomarkers more sensitive than PET scans in detecting obesity’s impact on Alzheimer’s pathology.
Read More